AbCellera (ABCL) Director Michael R. Hayden Donates 50,000 Shares

What Happened
Michael R. Hayden, a director of AbCellera Biologics Inc. (ABCL), reported a charitable donation of 50,000 common shares on August 11, 2026. The shares were disposed as a gift (transaction code G) and no cash proceeds were received (reported price $0.00).

Key Details

• Transaction date: August 11, 2026; Form 4 filed August 13, 2026 (appears timely under Section 16 reporting rules).
• Shares donated: 50,000 common shares; reported transaction price $0.00 (gift).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnote F1: The donation was made by Genworks 2 Consulting, Inc. on August 11, 2026.
• Footnote F2: The shares are held by Genworks 2 Consulting, Inc.; the reporting person’s spouse has sole voting and investment power over those shares. The reporting person disclaims beneficial ownership except for any indirect pecuniary interest.

Context
Gifts are non‑market transactions and do not directly signal the insider’s view of the stock price. Here, the transfer was executed via a consulting entity controlled (voting/investment power) by the reporting person’s spouse, and the reporting person disclaims direct beneficial ownership aside from any indirect pecuniary interest.